´Innovations and new business strategies in Dutch Life Sciences´
The Dutch Life Sciences & Health industry includes nowadays 3100 R&D life Sciences companies and 420 biopharmaceutical companies. Together with 13 universities and 8 university medical centres the industry is constantly innovating when it comes to research and development. Behind this lies the convergence of science and technology, leading a new era of healthcare, and an unprecedented growth in innovation and business. The conference showcases the latest innovations and young companies that apply new business strategies to bring these innovations to patient.
They are happy to announce their first keynote speakers! Together with their partners they have created a very inspiring and dynamic programme for the 18th Dutch Life Sciences conference with sessions on the following topics:
- Digital Healthcare: lessons learned and challenges ahead
- Supply chain challenges and strategies
- Spin-out strategies
- Towards the production of your first medicinal product
- RNA therapeutics: scientific breakthroughs, challenges and business strategies
- Regenerative medicines: bringing regenerative technology of the future to patients today
Furthermore the Venture Challenge award for the best startup company will be announced and young companies pitch their venture at the Investors forum.
We hope to meet you in person on November 24, 2022 in Leiden!
Since we were sold out the latest edition and had to disappoint many of you, we have already opened the registration. So ensure your participation and book your ticket now!
If you want to stay informed about the latest updates about this event, sign up here.